# Veralto Corp

Veralto Corp is an Asset Manager based in Waltham, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Waltham, United States
- **Region:** North America
- **Address:** Waltham, MA, United States
- **Founded:** 2023
- **Assets under management:** Undisclosed
- **Website:** veralto.com

## Regulatory record

- **Reports private funds:** No

## About

Veralto was launched in October 2023 when Danaher separated its Environmental and Applied Solutions segment into an independent public company. Jennifer Honeycutt, a Danaher veteran who previously ran the company's $1B life-sciences platform, was named CEO. The spinout concluded a three-year restructuring at Danaher that saw higher-growth biotech and diagnostics businesses consolidated under one roof while the steadier, regulation-driven water and product-identification units were packaged into Veralto. The company operates through two segments. Water Quality — the larger of the two — sells analytical instrumentation, reagents, and services under brands like Hach, ChemTreat, and Trojan Technologies, tracking contaminants for municipal treatment plants and industrial cooling towers. Product Quality & Innovation supplies marking and coding systems (Videojet) plus packaging-design software (Esko) to consumer-goods manufacturers. The strategy is industrial consolidation: Veralto acquires founder-owned metrology and compliance-tool companies, folds them into Danaher-derived business-system discipline, and benefits from replacement-part revenue streams that are contractually sticky. In 2024 the company completed multiple bolt-on acquisitions in the water-analytics space. The firm employs roughly 16,000 people and operates across more than 120 countries, with key manufacturing and service hubs in the United States, Germany, China, and India. In the twelve months following its separation from Danaher, Veralto generated approximately $5 billion in revenue. November 2024: Veralto closed its first full year as an independent company, reporting Q3 revenue of $1.32 billion with recurring consumables and service streams contributing roughly two-thirds of segment sales, consistent with the installed-base economics the spinout was designed to surface. Veralto's architecture is a structural answer to the conglomerate-discount problem. Rather than managing a portfolio of unrelated subsidiaries, both reporting segments are organized around the same economic engine — installed instrumentation bases that require constant reagent refills, calibration services, and software updates. That shared business model makes the two segments functionally interchangeable for capital allocation, a design Danaher explicitly chose when deciding which assets to spin rather than sell.

## Sectors

- Industrial Tech
- Energy Transition & Renewables

## People

- Jennifer L. Honeycutt — President and Chief Executive Officer

## Questions

### How does Veralto generate revenue?

Roughly two-thirds of Veralto's revenue comes from recurring streams — consumables like chemical reagents and ink cartridges, equipment service contracts, and software subscriptions — with the balance from one-time instrument sales. This installed-base dynamic makes revenue more predictable than a pure capital-equipment manufacturer and was the primary reason Danaher structured the spinout around these specific assets (per the firm, November 2024).

### Which industries does Veralto serve?

The Water Quality segment serves municipal drinking-water and wastewater utilities, industrial process-water operators, and environmental testing labs. The Product Quality & Identification segment serves consumer-packaged-goods companies, pharmaceutical manufacturers, and e-commerce distribution centers that require lot-level traceability on packaging. Both segments are regulated industries where compliance requirements create demand inelasticity.

### Who runs investment decisions at Veralto?

Capital-allocation decisions sit with the CEO and the corporate development team, with segment-level presidents identifying bolt-on acquisition targets within their respective verticals. The board's capital-allocation committee — staffed by former Danaher executives — reviews all transactions above a materiality threshold. Veralto does not operate a separate fund-management entity; it is a publicly traded operating company (per the firm's proxy statement, 2024).

### How is Veralto different from Danaher now?

Danaher retained the diagnostics, life-sciences, and biotechnology businesses that carry higher revenue growth but also higher R&D intensity and regulatory risk. Veralto received the lower-growth but higher-recurring-revenue environmental and applied-solutions units, which require less capital reinvestment and generate steadier free cash flow. The separation lets each management team optimize for a different investor base without cross-subsidizing capital budgets.

## Related profiles

- [T. Rowe Price Group](https://altss.com/profile/price-t-rowe-group-inc)
- [Labcorp](https://altss.com/profile/labcorp-holdings-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/veralto-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology